a public good project by the
Synthesis
Company
of California

© 2026

Stephen T. Worland | doi.page

0 works0 citations0 h-index

Stephen T. Worland

Therapeutics Clinical Research(US)Advanced Cancer Therapeutics(US)

Publications by Year

Research Areas

Economic Theory and Institutions, Viral Infections and Immunology Research, RNA and protein synthesis mechanisms, Respiratory viral infections research, Political Philosophy and Ethics

Most-Cited Works

→ Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein(1994)357 cited
→ Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes(1999)316 cited
→ Translation control of the immune checkpoint in cancer and its therapeutic targeting(2019)259 cited
→ Inducible overexpression, purification, and active site mapping of DNA topoisomerase II from the yeast Saccharomyces cerevisiae(1989)251 cited
→ In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C Protease(1999)223 cited
→ Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P₁ Lactam Moieties as l-Glutamine Replacements

(1999)

189 cited

→ Design, Synthesis, and Evaluation of Nonpeptidic Inhibitors of Human Rhinovirus 3C Protease(1996)145 cited

→ Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure−Activity Studies of Orally Bioavailable, 2-Pyridone-Containing Peptidomimetics(2002)142 cited

→ Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 2. Peptide Structure−Activity Studies(1998)111 cited

→ Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 1. Michael Acceptor Structure−Activity Studies(1998)92 cited